Putnam Investments’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-24,092
Closed -$606K 1322
2016
Q4
$606K Sell
24,092
-74,418
-76% -$1.88M ﹤0.01% 1098
2016
Q3
$2.77M Sell
98,510
-88,669
-47% -$2.27M 0.01% 757
2016
Q2
$4.62M Buy
187,179
+87,960
+89% +$2.18M 0.01% 652
2016
Q1
$2.19M Buy
+99,219
New +$2.64M 0.01% 926
2013
Q3
Sell
-23,609
Closed -$327K 1515
2013
Q2
$327K Buy
+23,609
New +$335K ﹤0.01% 1384

Other funds holding PMC

Putnam Investments's PMC Position: Q1 2017 in Review

Putnam Investments sold out of PharMerica Corporation (PMC) in Q1 2017, closing a stake of 24,092 shares — an estimated $606K sold.

Putnam Investments first reported a position in PMC in Q2 2013 and held it in 5 quarters. The position peaked at $4.62M in Q2 2016. 152 funds tracked by Wall St. Rank hold PMC as of Q1 2017.

  • Putnam Investments reported no remaining PharMerica Corporation position as of Q1 2017 after selling out during the quarter.
  • Putnam Investments sold 24,092 PharMerica Corporation shares in Q1 2017, an estimated $606K.
  • Putnam Investments first reported a position in PharMerica Corporation in Q2 2013 and held it in 5 quarters.
  • Putnam Investments's PharMerica Corporation position peaked at $4.62M in Q2 2016.
  • 152 funds tracked by Wall St. Rank held PharMerica Corporation as of Q1 2017.

Based on Putnam Investments's 13F filing for Q1 2017, filed 15 May 2017.